Clinical significance of cripto-1 expression in lung adenocarcinoma

Hua Zhang; Bin Zhang; Liuwei Gao; Lianmin Zhang; Kaikai Zhu; Runfen Cheng; Changli Wang

doi:10.18632/oncotarget.15761

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Clinical Research Papers:

Clinical significance of cripto-1 expression in lung adenocarcinoma

Hua Zhang, Bin Zhang, Liuwei Gao, Lianmin Zhang, Kaikai Zhu, Runfen Cheng and Changli Wang _

PDF | HTML | How to cite

Oncotarget. 2017; 8:79087-79098. https://doi.org/10.18632/oncotarget.15761

Metrics: PDF 1659 views | HTML 2491 views | ?

Abstract

Hua Zhang1,2,3,4,*, Bin Zhang1,2,3,4,*, Liuwei Gao1,2,3,4,*, Lianmin Zhang1,2,3,4, Kaikai Zhu2,3,5, Runfen Cheng2,3,5 and Changli Wang1,2,3,4

1 Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

2 National Clinical Research Center for Cancer, Tianjin, China

3 Key Laboratory of Cancer Prevention and Therapy, Tianjin, China

4 Tianjin Lung Cancer Center, Tianjin, China

5 Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

* These authors have contributed equally to this work

Correspondence to:

Changli Wang, email:

Keywords: Cripto-1, immunohistochemistry, lung adenocarcinoma, epidermal growth factor receptor, prognosis

Received: June 29, 2016 Accepted: February 20, 2017 Published: February 27, 2017

Abstract

Cripto-1 can promote tumourigenesis and may be a potential prognostic biomarker in several malignancies, yet little is known about this protein in lung adenocarcinoma (LAC). The aim of this study was to evaluate the prognostic value of cripto-1 expression in a cohort of patients with LAC. Tumours from 290 patients with pathologically confirmed LAC were used for an immunohistochemical analysis of cripto-1 expression. The correlation between cripto-1 expression and the clinicopathological parameters of patients, EGFR-TKI sensitivity was analysed. Significant associations between cripto-1 expression and pT status, pN status, pTNM status, E-cadherin expression and EGFR-TKI sensitivity were identified. Compared with patients with low cripto-1 expression, patients with high cripto-1 expression exhibited significantly poorer progression-free survival (PFS) and overall survival (OS). Moreover, multivariate analyses showed that high cripto-1 expression was an independent predictor of worse survival of patients with LAC. The combination of cripto-1 expression and serum CEA level was correlated with both PFS and OS. In conclusion, cripto-1 may be a potential prognostic biomarker of survival in patients with LAC.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 15761

Publication Alerts

Oncoscience

Post-Publication Promotion

Clinical Research Papers:

Clinical significance of cripto-1 expression in lung adenocarcinoma

Abstract